JB Chemicals & Pharmaceuticals Limited — Updates, 07-01-2026: General Updates
07-01-2026 | 02:54 pm
07-01-2026 | 02:54 pm
J. B. Chemicals & Pharmaceuticals' board approved an additional investment of up to Rs. 18 Cr into its wholly-owned Dubai subsidiary, Unique Pharmaceutical Laboratories, FZE. This cash infusion supports UPL FZE's operational needs. The subsidiary, engaged in medicines trading, reported AED 627,639 revenue for FY24-25.
No comments yet. Be the first to comment!
All announcements from JB Chemicals & Pharmaceuticals Limited
